We provide you with 20 years of free, institutional-grade data for RDY stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of RDY. Explore the full financial landscape of RDY stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| MUNNIRPALLAM MADHU SUNDAR SUBRAMANIAN | Initial | 2026-04-10 | |||
| AGHANIAN PATRICK RUDOLF | Initial | 2026-04-01 | |||
| KALAWADIA MILAN KANTILAL | Initial | 2026-04-01 | |||
| MOTUPALLI VENKATA RAMANA | Initial | 2026-04-01 | |||
| KULKARNI SUSHRUT | Initial | 2026-04-01 | |||
| BHETHANABOTTLA SRINIVASA PHANIMITRA | Initial | 2026-04-01 | |||
| MANNAM VENKATA NARASIMHAM | Initial | 2026-04-01 | |||
| SAPRA DEEPAK | Initial | 2026-04-01 | |||
| Reddy K Satish | Initial | 2026-03-20 |
The information provided in this report about RDY stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Dr. Reddy's Laboratories Limited(NYSE:RDY) 
Dr. Reddy's Laboratories Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. Dr. Reddy's Laboratories Limited operates as an integrated pharmaceutical...
Website: http://www.drreddys.com
Founded: 1984
Full Time Employees: 21,650
CEO: Erez Israeli
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
